Adjuvant abemaciclib combined with endocrine therapy (ET) has demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared with standard ET in ...
In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen receptor antagonist and degrader (SERD), when given as an adjuvant therapy ...
Considerable evidence exists that sodium-glucose cotransporter 2 inhibitors (SGLT2i) can improve cardiovascular risk and reduce the socioeconomic burden of conditions like heart disease and type 2 ...
Wendy Wisner is a journalist and international board certified lactation consultant (IBCLC). She has written about all things pregnancy, maternal/child health, parenting, and general health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback